Top Markets
#1 Akedo Akedo +55.65%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +47.96%
#4 Velvet Velvet +38.39%
#5 Black Phoenix Black Phoenix +34.09%
#6 Cross Cross +24.27%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.20%
#8 QANplatform QANplatform +14.54%
#9 Perle Perle +13.89%
#10 Bitway Bitway +13.56%
Coin of the day
Akedo Akedo
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Hisse Senetlerindeki Sıralama #39104
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Hisse Fiyatı
$0.02243487
Son senkronizasyon: 2025-06-04
Piyasa Değeri
$650.09K
Değişim (1 gün)
0.39%
Değişim (1 yıl)
0.00%
Ülke
SE
Ticaret Lipidor AB (publ) (LIPI)

Kategori

Healthcare
Lipidor AB (publ) (LIPI) için P/B oranı
August 2026 itibarıyla P/B oranı TTM: 12.04
Lipidor AB (publ) şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/B oranı (TTM) 12.04'dir. 2023 yılının sonunda şirketin P/B oranı -1.56 idi.
Lipidor AB (publ) için P/B oranı geçmişi 2016 - 2026 arası
Her yılın sonunda P/B oranı
Yıl P/B Oranı Değiştir
2026 (TTM) 12.04 0.94%
2024 11.93 -862.92%
2023 -1.56 -115.74%
2022 9.94 83.15%
2021 5.43 4.17%
2020 5.21 -57.99%
2019 12.40 47.15%
2018 8.43 -75.94%
2017 35.02 -76.02%
2016 146.04 0.00%
Benzer şirketler veya rakipler için P/B oranı
Şirket P/B Oranı P/B Oranı Farkı Ülke
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 32.9295 173.44%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.3617 -38.87%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -66.8597 -655.19%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 -29.60%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7.0166 -41.74%
US